Searched for
PHASE 1 TRIAL
India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- First AI-designed 'universal vaccine' tested in humans: UK researchersA groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab...
- India overhauls inflation framework with new Producer Price Index, revised WPIIndia is set to introduce a new Producer Price Index and a revamped Wholesale Price Index from June 15. This significant overhaul aims to a...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- This day in history, May 30: From Joan of Arc's execution to the first Indy 500, women's pro baseball league debut and Mariner 9's launch to MarsThis day in history, May 30, has witnessed some of the world's most significant political, military, scientific and cultural developments. ...
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
- Singapore Badminton Open 2026: PV Sindhu falls to nemesis An Se Young; Satwik-Chirag into semifinalsIndia's PV Sindhu exited the Singapore Open quarterfinals after a loss to Korea's An Se Young. However, the men's doubles pair Satwiksairaj...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- Marco Rubio — The bridge between the Trump–Modi economic doctrineUS Secretary of State Marco Rubio visits India to forge a new economic alliance. This partnership, driven by leaders like President Trump a...
- Why West’s crypto rules matter for East’s financial futureThe US CLARITY Act addressing legal uncertainty will shape global crypto regulation. Eastern hubs like the UAE and Singapore are moving ahe...
- Eli Lilly’s obesity drug shows up to 30% weight loss in trialEli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This onc...
- ET Prime Special Series: Multibagger or IBC - Part 59: Japan taught it. Tata bought it. Now EVs will test this auto ancillaryThis is a story about a company that is simultaneously an asset and an anomaly. An asset because it builds a tangible, necessary product, g...
- India's Rs 1.7 lakh crore fuel crisis may have found an unlikely fixIndia faces high energy import costs and a weakening ₹. A Monaco company, FOWE Eco Solutions, presents a water-based fuel emulsion technolo...
Load More
